Revision as of 23:09, 27 November 2020 by imported>LinXED
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Spirendolol
|
| Names
|
| IUPAC name
4-[3-(tert-Butylamino)-2-hydroxypropoxy]spiro[3H-indene-2,1'-cyclohexane]-1-one
|
| Identifiers
|
|
|
|
|
|
|
| ChemSpider
|
|
|
|
|
| UNII
|
|
InChI=1S/C21H31NO3/c1-20(2,3)22-13-15(23)14-25-18-9-7-8-16-17(18)12-21(19(16)24)10-5-4-6-11-21/h7-9,15,22-23H,4-6,10-14H2,1-3H3 Key: YLBMSIZZTJEEIO-UHFFFAOYSA-N InChI=1/C21H31NO3/c1-20(2,3)22-13-15(23)14-25-18-9-7-8-16-17(18)12-21(19(16)24)10-5-4-6-11-21/h7-9,15,22-23H,4-6,10-14H2,1-3H3 Key: YLBMSIZZTJEEIO-UHFFFAOYAB
|
CC(C)(C)NCC(COC1=CC=CC2=C1CC3(C2=O)CCCCC3)O
|
| Properties
|
|
|
C21H31NO3
|
| Molar mass
|
345.483 g·mol−1
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
| Infobox references
|
|
|
|
Tracking categories (test):
Spirendolol is a beta adrenergic receptor antagonist.[1]
References
- ↑ Mostaghim, R; Maddox, YT; Ramwell, PW (1986). "Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents". The Journal of Pharmacology and Experimental Therapeutics 239 (3): 797–801. PMID 2879033.
 | Original source: https://en.wikipedia.org/wiki/Spirendolol. Read more |
